Výsledky vyhledávání

Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group

Autor: A. Jorgensen, C. Cripps, R. Mayer Steinacker, Y. Merrouche, A. Man, G. Batist, J. Schuller, M. Wirth, S. Pyrhonen, G. Vantrappen, H. Bergermann, B. Weinerman, A. Jakobsen, A. Scaletzky, J. Seitz, Jean A. Maroun, H. Ravn, J. Bury, E. Francois, D. Lutz, R. Johansson, H. Smith, C. Blaes, F. Porzsolt, B. May, E. Pannuti, M. Budde, John A. Levi, Peter Sherman, J. Skillings, R. Goel, J. Heise, M. Froimtchuk, P. Guillou, M. De Lourdes Lopes De Oliveira, W. Kocha, P. Lankisch, P. Selby, K. Bertelsen, M Namer, John Stewart, Euan Walpole, R. Mertelsmann, J. Primrose, S. Holmstrom, P. Carey, J. Mejlholm, David R. Bell, Damien Thomson, U. Ward, G. Boos, Allan Solomon Zimet, V. Fosser, R. Luykx, T. Shore, G. Massimini, Stephen P. Ackland, Michael D. Green, E. Lindegaard Madsen, J. Salomon, M. Colleoni, A. K. L. Yap, John Zalcberg, G. Cartei, M. Schupp, E. E. Holdener, M. Giovannini, R. Egeli, C. Berg, P. Rebattu, Y. Becouarn, N. Brunsgaard, L. Cockey, C. Sodomann, L. Lepoutre, M. Reginster, M. Kjaer, E. Sandberg, J. Greving, L. De Facq, S. Somers, R. Brunet, O. P. Isokangas, E. Van Cutsem, C. Gadeberg, U. Fogl, E. Bajetta, P. Rougier, V. Kataja, D. Dalley

Publikováno v: Journal of Clinical Oncology. 13:921-928

PURPOSE To compare the efficacy and toxicity profiles of a combination of fluorouracil (5-FU) with recombinant human interferon alfa-2a (Roferon-A; Hoffman La-Roche AG, Basel, Switzerland) versus the combination of 5-FU with leucovorin (LV) in the tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d48f67e251086e9b5251c045bb93eb
https://doi.org/10.1200/jco.1995.13.4.921

Zobrazit plný text záznamu

Opinions concerning eutanasia, life sustaining treatment and acceleration of death: results of an Italian Association of Medical Oncology (AIOM) survey

Autor: N. La Verde, Vittorina Zagonel, V. Fosser, M. Venturini, F. Boccardo, Carmelo Iacono, Oscar Bertetto, Chiara Catania, Davide Radice, Laura Adamoli

Background Advance directives, acceleration of death, euthanasia and ‘life-sustaining treatment’ have sparked much heated debate among the media, the public, doctors and political leaders. We evaluate the personal opinions of Italian Association

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d12a586ad944300e76ff68f253c690
http://hdl.handle.net/11567/215645

Zobrazit plný text záznamu

Cardiac toxicity of high-dose chemotherapy

Autor: Paolo Morandi, R Raimondi, G M Benvenuto, V. Fosser, Pier Adelchi Ruffini

Publikováno v: Bone marrow transplantation. 35(4)

Cardiac toxicity is an uncommon but potentially serious complication of high-dose (HD) chemotherapy and little is known about incidence, severity and underlying mechanisms. We have systematically reviewed the literature of the last 30 years to summar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2110ce09c3be6987c442f8806ad1a0c
https://pubmed.ncbi.nlm.nih.gov/15543194

Zobrazit plný text záznamu

Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study

Autor: C. Presot, M. S. Dionisi, A. Lucenti, M. Minelli, M. Antimi, P. Manente, Massimo Federico, E. Sansoni, C. M. Foggi, T. Buniva, D. Negri, Giovanni Quarta, Albano Del Favero, Maurizio Tonato, D. Amadori, C. Epifani, M. Maltoni, G. Gorzegno, M. Giordano, C. Milandri, R. Casaretti, G. Ciccarese, P. Marchei, F. De Vita, I. Carreca, V. Fosser, D. Donati, G. Cruciani, S. Della Gaspera, F. M. Gioffré, L. De Sio, B. Agostara, Verena De Angelis, Roberto Sabbatini, Fausto Roila, R. Sabbioni, R. Maccaferri, G. Villani, G. Bernardo, M. R. Strada, A. Contu, G. Amunni, A. Villanucci, S. Schiavon, S. Tumolo, A. Pazzola, C. Caroti, L. Merlini, A. Amodio, M. Marzi, G. Garofolo, G. Catalano, L. Dogliotti, P. Alessadroni, P. Malacarne, M. Ceccolini, F. Conti, F. Di Costanzo, L. Rausa, M. A. Palladino, M. Lopez, L. Montanari, L. Gallo, G. Iodice, G. L. Cetto, A. Venuti, S. Mazzotta, M. T. Cattaneo, C. Pacilio, G. Palmiotti, R. Nortilli, R. Forcignanò, G. Troccoli, A. Giglio, G. Comella, G. Rosati, Enzo Ballatori, S. Amici, Roberta Depenni, Vittorio Silingardi, S. Porrozzi, L. Meneghetti, G. Muran, B. Orlandini

Publikováno v: Scopus-Elsevier

Aims and Background The necessity of an antiemetic prophylaxis in patients treated with chemotherapy of low emetogenic potential, such as 5-fluorouracil ± folinic acid fractionated over several consecutive days, is controversial. The aim of the stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0023512f3fb0b9df8ba47542b191434
https://pubmed.ncbi.nlm.nih.gov/11989589

Zobrazit plný text záznamu

Oral ondansetron (GR38032F) for the control of acute and delayed cyclophosphamide-induced emesis

Autor: R, Rosso, E, Campora, G, Cetto, V, Fosser, M, Marangolo, C, Oliva

Publikováno v: Anticancer research. 11(2)

The efficacy of the serotonin antagonist ondansetron (GR38032F, Glaxo) was evaluated in the prevention of nausea and vomiting induced by combinations containing cyclophosphamide (CTX) greater than or equal to 600 mg/m2 IV day. At their first treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::332f3c9012a01a09d8d4ade39e13d891
https://pubmed.ncbi.nlm.nih.gov/1829602

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání